What we found on the web about Rituximab
Rituximab - Wikipedia, the free encyclopedia
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells.
Hairy cell leukemia - Wikipedia, the free encyclopedia
Rituximab has successfully induced a complete response in Hairy Cell-Variant. [32] Rituximab's major side effect is serum sickness, commonly described as an "allergic reaction ...
Hotline: May, 2006 - Abatacept and Rituximab
Hotline Abatacept and Rituximab . Two new biologic agents, abatacept (Orencia) and rituximab (Rituxan), have recently been approved for the treatment of rheumatoid arthritis.
HIGHLIGHTS OF PRESCRIBING INFORMATION
U.S. BL 103705/5297 Amendment: Rituximab  Genentech, Inc. 1 of 31/Regional (RA): Rituxan Final HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the ...
Rituximab (Rituxan) in Lymphomas
Rituximab is a new form of treatment for Non-Hodgkin Lymphomas (NHL). It binds to special molecules on the surface of cancer cells and inactivates them. Read on to find out how ...
Rituximab
Drug details for Rituximab. ... Rituximab is available for intravenous (IV) use. How It Works. Rituximab belongs to a group of medicines known as monoclonal antibodies.
Rituximab Injection: MedlinePlus Drug Information
[Posted 09/11/2008] Genentech informed healthcare professionals of revisions to prescribing information for rituximab (Rituxan) regarding a case of progressive multifocal ...
arc :: Drug information: Rituximab
Rituximab (brand name MabThera) is a new type of drug which removes antibody-producing white blood cells called B-cells. Antibodies are proteins which are produced by the body in ...
Rituximab - Medpedia
Rituximab is a drug that suppresses the immune system. This drug is a genetically engineered antibody that functions like the antibodies that the body produces naturally. It was ...
Rheumatoid arthritis (refractory) - rituximab
The summary of the published technology appraisal on Rheumatoid arthritis (refractory) - rituximab. It links to the published guidance and key documents.
Rituximab Helps Patients with Recurrent Lymphomas - National Cancer ...
Two studies from Germany showed the targeted therapy rituximab (Rituxan®) to be effective in treating recurrent or refractory follicular and mantle cell lymphomas. Findings from ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Rituximab

Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Rituximab
Genmab Announces Results for the Nine Months Period of 2009
StreetInsider.com
... refractory to methotrexate; a Phase II front line combination study in CLL; a Phase II front line combination study in non-Hodgkin's lymphoma (NHL) and a pivotal Phase III study in rituximab refractory NHL. The overall response rate in ...
Six infection-related deaths reported after treatment with MabCampath ...
Xagena Medical News
... deaths, reported from a trial ( CALGB10101 ) in which previously untreated, symptomatic B-cell chronic lymphocytic leukemia patients were treated with Fludarabine ( Fludara ) and Rituximab ( MabThera, Rituxan ) followed by Alemtuzumab ....
ITP: New hope for rare blood disorder sufferers
Daily Telegraph
Lt Col Black was then put on a series of drugs including immunosuppressives, to slow the rate of platelet-destruction, and rituximab, an antibody treatment also used to manage lymphoma. Nothing worked. Finally, he was prescribed Nplate, (ro...
Genmab Announces Start of Ofatumumab Phase III Head to Head Study in ...
Stockhouse
Summary: Genmab has initiated a Phase III study of Arzerra ofatumumab in diffuse large B-cell lymphoma. Genmab A/S (Copenhagen:GEN) announced today the initiation of a Phase III study of Arzerra (TM) ofatumumab plus chemotherapy versus ritu...
Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update ...
Yahoo Finance
The ZEVALIN therapeutic regimen consists of three components: rituximab, Indium-111 (In-111) radiolabeled ZEVALIN for imaging, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. The ZEVALIN therapeutic regimen is a form of cancer thera...